Himalaya Nutravedics India IPO GMP today is TBA. Investors can use this GMP along with price band and subscription status for a better IPO review.
Upcoming
SME IPO
HIMALAYA
Himalaya Nutravedics India IPO GMP & Subscription Status Today
Himalaya Nutravedics manufactures and supplies a range of Ayurvedic and nutraceutical products across multiple dosage forms, including softgel capsules, hardgel capsules, tablets, liquid orals, medicated oils, and protein powders. The company operates through a single integrated manufacturing facility located in Hyderabad, Telangana. Its product portfolio covers therapeutic categories such as pain management, infertility, women’s wellness, gut health, neurological support, and general wellness. The business generates revenue primarily from the sale of Ayurvedic formulations, alongside nutraceutical offerings. The company operates mainly through a business-to-business model, supplying products to stockists, distributors, and third-party contract manufacturing clients across various states in India. It also undertakes custom contract manufacturing for corporate clients under their own brand names utilizing its manufacturing infrastructure. Furthermore, the company is expanding its market presence into direct-to-consumer sales channels through digital platforms, e-commerce marketplaces, and quick commerce delivery services.
- Price Band
- ₹100.00 - ₹106.00
- Lot Size
- 1,200 Shares
- Bidding Closes
- 24 Sept 2026
- Listing Date
- 29 Sept 2026
Current GMP Status
-
GMP update awaited
Est. Listing Gain
TBA
Last Trend
TBA
Listing Price
TBA
Retail Entry
₹2,54,400
IPO Details
Complete IPO information
| Current GMP | - |
|---|---|
| Estimated Listing Gain | TBA |
| Price Band | ₹100.00 - ₹106.00 |
| Issue Price | Approx ₹26.50 Crores |
| Listing Price | TBA |
| Lot Size | 1,200 Shares |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | BSE SME |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 29 Sept 2026 |
| Minimum Investment | ₹2,54,400 |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Himalaya Nutravedics India is priced at ₹106 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,54,400 to participate in this SME issue.
Among the strengths highlighted in Himalaya Nutravedics India's IPO documents: Integrated manufacturing facility capable of producing multiple dosage forms.; Diverse Ayurvedic and nutraceutical product portfolio across key therapeutic areas..
Investors should also weigh the risk factors Himalaya Nutravedics India has disclosed, including: High revenue reliance on Ayurvedic products, accounting for over 90% of sales..
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
01
Bidding Opens Next
22 Sept 2026
02
Bidding Closes
24 Sept 2026
03
Allotment
25 Sept 2026
04
Listing
29 Sept 2026
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,400 | ₹2,54,400 |
| Retail Maximum | 2 Lot | 2,400 | ₹2,54,400 |
| S-HNI Minimum | 3 Lot | 3,600 | ₹3,81,600 |
| S-HNI Maximum | 7 Lot | 8,400 | ₹8,90,400 |
| B-HNI Minimum | 8 Lot | 9,600 | ₹10,17,600 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Issue Notes
Important takeaways before applying
Strengths
- Integrated manufacturing facility capable of producing multiple dosage forms.
- Diverse Ayurvedic and nutraceutical product portfolio across key therapeutic areas.
- Established B2B distribution network with presence across 17 Indian states.
- Track record of strong revenue and net profit growth over recent fiscal years.
- In-house quality assurance and control capabilities across production processes.
Risks
- High revenue reliance on Ayurvedic products, accounting for over 90% of sales.
- Significant revenue concentration from top 10 customers representing over 80% of revenue.
- Operations from a single leased manufacturing facility located in Hyderabad, Telangana.
- Pending trademark opposition proceedings for corporate logos and mark applications.
- History of negative cash flows from operating activities due to working capital needs.
FAQ
Himalaya Nutravedics India IPO FAQs
Himalaya Nutravedics India IPO price band is Rs 100.00 to Rs 106.00. Check the latest issue price, lot size and GMP together before applying.
Himalaya Nutravedics India IPO open date is 22 Sept 2026, close date is 24 Sept 2026, and listing date is 29 Sept 2026.
Himalaya Nutravedics India IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,54,400.
Himalaya Nutravedics India is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Himalaya Nutravedics India IPO subscription status currently shows Subscription data is currently awaited.
Himalaya Nutravedics manufactures and supplies a range of Ayurvedic and nutraceutical products across multiple dosage forms, including softgel capsules, hardgel capsules, tablets, liquid orals, medicated oils, and protein powders. The company operates through a single integrated manufacturing facility located in Hyderabad, Telangana. Its product portfolio covers therapeutic categories such as pain management, infertility, women’s wellness, gut health, neurological support, and general wellness. The business generates revenue primarily from the sale of Ayurvedic formulations, alongside nutraceutical offerings. The company operates mainly through a business-to-business model, supplying products to stockists, distributors, and third-party contract manufacturing clients across various states in India. It also undertakes custom contract manufacturing for corporate clients under their own brand names utilizing its manufacturing infrastructure. Furthermore, the company is expanding its market presence into direct-to-consumer sales channels through digital platforms, e-commerce marketplaces, and quick commerce delivery services.
Himalaya Nutravedics India IPO issue size is 26.50 and the expected allotment date is 25 Sept 2026.
Community discussion
Comments
Share a useful question or insight about Himalaya Nutravedics India.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...